Falsified and substandard medicines trafficking: A wakeup call for the African continent
Public Health in Practice, 2022 While great effort is being placed on reducing disease burdens in Africa, the circulation of falsified and substandard medicines in the continent are reversing the hard-won gains.
Yusuf Hassan Wada, Garba M Khalid
exaly +5 more sources
Medicine Access @ Point of Care, 2022 Substandard and falsified (SF) medicines are a global health challenge with the World Health Organization (WHO) estimating that 1 in 10 of medicines in low- and middle-income countries (LMICs) are SF. Antimicrobials (i.e.
Bahijja Tolulope Abraham +1 more
exaly +4 more sources
A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives [PDF]
J Med Access, 2022 Simultaneous expansion of the Internet and increased globalisation of the pharmaceutical industry have meant medication can be accessed transnationally from both legal and illicit sources. This has coincided with the rise of substandard and falsified medicines (SFMs) online.
Tim Mackey +2 more
exaly +4 more sources
Substandard and falsified medicine recalls in the legitimate supply chain: a systematic review of evidence [PDF]
BMJ OpenObjectives To compare international substandard and falsified (SF) medicine recall trends from published research papers based on governmental databases, summarise the extent of the problem in the legitimate supply chain, and identify ways to manage the ...
Bernard D Naughton, Izabella Fryze
doaj +4 more sources
Combatting substandard and falsified medicines: a view from Rwanda. [PDF]
PLoS Medicine, 2013 Agnes Binagwaho and colleagues describe Rwanda's experience of pharmacovigilance for malaria and tuberculosis, and call for a global treaty and leadership by the World Health Organization to address the global manufacture and trade in substandard and falsified medicines.
Agnes Binagwaho +10 more
doaj +6 more sources
Evaluating Low-Cost Optical Spectrometers for the Detection of Simulated Substandard and Falsified Medicines [PDF]
Applied Spectroscopy, 2020 Distribution of substandard and falsified (SF) medicines is on the rise, and its impact on public health, particularly in low-resource countries, is becoming increasingly significant. Portable, nondestructive screening devices can support regulatory authorities in their defense against the spread of SF medicines.
Wenbo Wang +2 more
exaly +5 more sources
The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists [PDF]
BMJ Global Health, 2019 The global burden of substandard and falsified (SF) medicines is only beginning to be better understood. A 2017 literature review by WHO estimated a 10.5% observed failure rate of the analysed medical product samples in low-income and middle-income countries.1 The report also estimated that between 72 430 and 169 271 deaths in children under 5 with ...
Veronika J Wirtz +4 more
doaj +5 more sources
Substandard, falsified and unregistered medicines in Latin America, 2017-2018 [PDF]
Revista Panamericana de Salud Pública, 2020 Objective. To assess all the incidents of substandard, falsified and unregistered medicines in 2017 and 2018 in Latin America, determining the types of products affected, stages of the supply chain in which incidents were detected, quality deviations ...
Robin Rojas-Cortés
doaj +3 more sources
Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping review [PDF]
J Med AccessBackground: Both constrained access to essential medicines and combatting marketing of substandard and falsified (SF) medicines are unmet health sector goals in Africa. Objective: To answer the question of how improved access can ...
Majid Davari +2 more
exaly +4 more sources
Substandard and falsified medicine screening technologies [PDF]
AAPS Open, 2019 Substandard and falsified medicine screening technologies are invaluable tools for post-marketing surveillance of medicine quality, particularly in low- and middle-income countries.
Lukas Roth +2 more
doaj +2 more sources